Former Chief Financial Officer and Chief Strategy Officer · BeOne Medicines Ltd. (ONC)

Howard Liang

A named executive officer of BeOne Medicines in every fiscal year CompBrief holds from FY2016 to FY2021. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$766,049

Salary $222,500Stock awards $0

FY2020: $3,760,536

6th of 6 named executive officers at BeOne Medicines by FY2021 total.

6 named officers on file for BeOne Medicines, FY2021

Howard Liang’s pay file — $29

  • 6 fiscal years of pay, line by line
  • 6 equity grants, each cited to its filing
  • ONC’s disclosed peer group of 15 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how BeOne Medicines’s whole pay program stands against its peers

  • BeOne Medicines’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ONC→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 29, 2022 (DEF 14A).

Free

Get Howard Liang’s full pay file as a PDF — free

More than this page: up to 10 years of Howard’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Howard Liang compensation by year

BeOne Medicines Summary Compensation Table · all 6 fiscal years held
In US dollars, as BeOne Medicines reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2016FY2017FY2018FY2019FY2020FY2021
Salary$350,001$380,000$425,000$435,000$443,333$222,500
Bonus$182,001$218,400$0$0$0$0
Stock awards$0$0$645,770$699,967$749,875$0
Option awards$3,392,840$3,017,750$2,583,182$2,799,967$2,249,990$531,949
Non-equity incentive——$278,375$251,213$305,938$0
Pension and deferred compensation$0$0$0$0$0$0
All other$7,875$8,100$8,250$8,400$11,400$11,600
Total$3,932,717$3,624,251$3,940,577$4,194,547$3,760,536$766,049

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: BeOne Medicines Ltd. DEF 14A filed April 29, 2022, accession 0001104659-22-053838, and prior-year filings. Open the filing on EDGAR.

How this page was built: the BeOne Medicines Ltd. filed document, accession 0001104659-22-053838. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2022.

$3.9M
$3.6M
$3.9M
$4.2M
$3.8M
$766K
FY16
FY17
FY18
FY19
FY20
FY21
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2020 year-end
TypeUnvested unitsValue at year-endExercise price
RSU56,901$1,130,973—
RSU55,887$1,110,819—
RSU26,182$520,397—
Option315,341—$13.42
Option156,325—$3.46
Option136,734—$12.34
Option348,985—$9.23

Per the Outstanding Equity Awards at Fiscal Year-End table in BeOne Medicines Ltd.'s FY2020 proxy; value at the fiscal year-end close, as the company printed it.

BeOne Medicines’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
John OylerFounder, Chief Executive Officer and Chairman$16,748,546
Xiaobin WuPresident, Chief Operating Officer and General Manager of China$9,639,220
Lai WangGlobal Head of Research and Development$6,454,871
Jane HuangFormer Chief Medical Officer, Hematology ( 16)$5,117,775
Julia WangChief Financial Officer$3,739,651
Howard Liang · this pageFormer Chief Financial Officer and Chief Strategy Officer$766,049

The full BeOne Medicines compensation record

free company brief

This page is one person within BeOne Medicines's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are BeOne Medicines's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Howard Liang's compensation dossier · One-time report. No refunds.